[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-460968-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-460968-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","over-expression-purification-and-kinetic-analysis-of-mycobacterium-tuberculosis-weca","Over-expression, purification, and kinetic analysis of Mycobacterium tuberculosis WecA","","The N-acetylglucosamine-1-phosphate transferase (WecA) is evaluated as a promising anti-tuberculosis drug target because it catalyzes a critical step in mycobacterial cell wall synthesis. WecA is challenging to obtain since it is a membrane protein with 11 transmembrane domains, so sufficient protein was produced using an Escherichia coli strain with T7 lysozyme-controlled expression. Purified WecA was generated by affinity chromatography, identified by mass spectrometry, and kinetic properties were determined by monitoring UMP formation. Tunicamycin showed competitive inhibition, supporting future elucidation of WecA catalytic mechanism and inhibitor development.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/over-expression-purification-and-kinetic-analysis-of-mycobacterium-tuberculosis-weca/460968/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/over-expression-purification-and-kinetic-analysis-of-mycobacterium-tuberculosis-weca/460968.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn Holloway","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is WecA considered a potential anti-tuberculosis drug target?","Question",{"text":63,"@type":64},"WecA catalyzes the first step in synthesis of the mycobacterial cell wall linker, a process essential for mycobacterial survival, and therefore represents a target for anti-tuberculosis therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was WecA protein obtained for kinetic study?",{"text":68,"@type":64},"WecA was expressed in an Escherichia coli strain with T7 lysozyme precisely regulating expression, then purified by affinity chromatography.",{"name":70,"@type":61,"acceptedAnswer":71},"What inhibitor was tested and what inhibition type was observed?",{"text":72,"@type":64},"Tunicamycin was tested and proved to be a competitive inhibitor based on the kinetic analysis using UMP detection.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},460968,1791077932,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of EnzymE InhIbItIon and mEdIcInal chEmIstry 2026, Vol. 41, no. 1, 2610028  \n[https://doi.org/10.1080/14756366.2025.2610028](https://doi.org/10.1080/14756366.2025.2610028)  \nReseaRch aRticle    \nOver-expression, purification, and kinetic analysis of Mycobacterium tuberculosis WecA  \nYishu Zhaoa, haiying Jiaa,b, Yan Wanga,b, shanshan shac, Dong ana, shufeng Yangd, lei Qianc,e, Yufang Mac and liming Xua   \nascientific research center, the second affiliated hospital of dalian medical university, dalian, china; bdepartment of Internal medicine, the second affiliated hospital of dalian medical university, dalian, china; cdepartment of biochemistry and molecular biology, dalian medical university, dalian, china; ddepartment of microbiology, dalian medical university, dalian, china; eadvanced Institute for medical sciences, dalian medical university, dalian, china  \nABSTRACT  \nthe N-acetylglucosamine-1-phosphate transferase (Weca)is a potential target for developing anti-tuberculosis drugs, due to its critical role in the synthesis of mycobacterial cell wall. the enzymatic study of Weca and the discovery of Weca inhibitors are therefore justified. however, Weca is a membrane protein with 11 transmembrane domains, making it difficult to be obtained, and even more difficult to [perform activity studies. in](perform activity studies. in) order to gain sufficient Weca protein for activity investigation, the Escherichia coli (E. coli) lemo21(De3) strain was utilised in this study. the expression level of Weca was precisely regulated by t7 lysozyme. Purified Weca was obtained by affinity chromatography and identified by mass spectrometry. the kinetic properties of Weca were determined based on the detection of the product UMP. in addition, tunicamycin proved to be a competitive inhibitor. these results will lay theoretical foundations for the elucidation of Weca catalytic mechanism and the development of Weca inhibitors.  \nIntroduction  \nARTICLE HISTORY  \nReceived 9 May 2025 Revised 24 November 2025  \naccepted 22 December 2025  \nKEYWORDS  \nMycobacterium tuberculosis;  \nN-acetylglucosamine- 1-phosphate transferase; Weca; membrane protein; tunicamycin  \ntuberculosis (tB) is a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb) . in 2024, there were an estimated 10.7 million new cases of tB and 1.23 million deaths1. Furthermore, the emergence of multidrug-resistant (MDR) tB and extensively drug-resistant (XDR) tB, as well as the hiV-associated tB made the disease exceptionally difficult to be treated2–4. therefore, it is required to explore novel tB drugs based on new potential drug targets.  \nthe distinguishing features of the mycobacterial cell wall is a well-recognised library of anti-tB drug targets5,6. the core structure of the mycobacterial cell wall is mainly composed of peptidoglycan (PG), arabinogalactan (aG), and mycolic acids7. a disaccharide linker, l-rhamnose-d-N-acetylglucosamine, which covalently attaches aG to PG (Figure 1(a)), is essential for the integrity of the cell wall structure and mycobacterial survival8. N-acetylglucosamine-1-phosphate transferase (Weca) catalyses the first step in the synthesis of the linker [disaccharide](disaccharide5. in)[5](disaccharide5. in)[. in](disaccharide5. in) the reaction catalysed by Weca, the GlcNac-1-P group is transferred from UDP-GlcNac to decaprenyl phosphate (c50-P), yielding a glycolipid c50-P-P-GlcNac8. Rv1302, the coding gene of Weca was proven to be essential for mycobacterial growth9, 10. therefore, Weca is a potential target for the development of anti-tB drugs. Furthermore, Weca was predicted to be a membrane protein with 11 transmembrane domains (Figure 1(B)). Based on the advantage that drugs targeting membrane proteins do not require cell permeability, Weca furthermore becomes an ideal anti-tB target.  \nin our previous study, we found that down-regulation of Weca enhanced the sensitivity of mycobacteria against rifampin, indicating that combining","cbCaidaNkVfiNAHn","https://ap.wps.com/l/cbCaidaNkVfiNAHn","pdf",1567261,11,"English","# Abstract\n# Introduction\n## Target selection and rationale\n## Role of WecA in cell wall linker synthesis\n## Production strategy and activity assay approach\n# Article history\n# Keywords","[{\"question\":\"Why is WecA considered a potential anti-tuberculosis drug target?\",\"answer\":\"WecA catalyzes the first step in synthesis of the mycobacterial cell wall linker, a process essential for mycobacterial survival, and therefore represents a target for anti-tuberculosis therapy.\"},{\"question\":\"How was WecA protein obtained for kinetic study?\",\"answer\":\"WecA was expressed in an Escherichia coli strain with T7 lysozyme precisely regulating expression, then purified by affinity chromatography.\"},{\"question\":\"What inhibitor was tested and what inhibition type was observed?\",\"answer\":\"Tunicamycin was tested and proved to be a competitive inhibitor based on the kinetic analysis using UMP detection.\"}]","Over-expression, purification, and kinetic analysis of Mycobacterium tuberculosis WecA | PDF",1790760199,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/23e19eb20e732384b6b114eb3e6a6e03.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c11d72240df48284e634327f25a9ae9c.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1b256975d3a60ad1edf5a2b48292af92.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/89a23ef3eacb6457dbb4bd7089e15e4e.webp",980,1306]